A detailed history of Core Cap Advisors, LLC transactions in Health Catalyst, Inc. stock. As of the latest transaction made, Core Cap Advisors, LLC holds 647 shares of HCAT stock, worth $5,260. This represents 0.0% of its overall portfolio holdings.

Number of Shares
647
Previous 647 -0.0%
Holding current value
$5,260
Previous $4,000 25.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$5.53 - $7.28 $3,577 - $4,710
647 New
647 $4,000
Q2 2022

Aug 11, 2022

BUY
$11.79 - $27.63 $1,414 - $3,315
120 New
120 $2,000
Q1 2022

Apr 29, 2022

SELL
$20.67 - $40.33 $2,480 - $4,839
-120 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$36.68 - $54.02 $4,401 - $6,482
120 New
120 $5,000

Others Institutions Holding HCAT

About Health Catalyst, Inc.


  • Ticker HCAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 54,723,400
  • Market Cap $445M
  • Description
  • Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accura...
More about HCAT
Track This Portfolio

Track Core Cap Advisors, LLC Portfolio

Follow Core Cap Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Core Cap Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Core Cap Advisors, LLC with notifications on news.